– UK, Cambridge – Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, today announced the appointment of Mark Keogh to its Board as Non-Executive Director.
“I am delighted to welcome Mark to the board of directors. Mark provided helpful advice to the Company as we concluded our recent investment round, and his appointment will enable us to continue to benefit from his substantial experience of business planning, financial operations, corporate finance and M&A. He will be an asset to the team and will contribute significantly to Metrion’s further growth and international development.” said Board Chairman, Dr Keith McCullagh.
The appointment follows the recent announcement of a £2.7m new equity investment led by Gresham House Ventures and is intended to strengthen the Board’s financial and corporate experience, in support of the planned international growth.
About Mark Keogh
Mark Keogh is a chartered accountant and civil engineer with more than 30 years experience of in senior financial management in multiple industrial sectors. Most recently he was Group CFO of Charles Taylor plc, where he facilitated the group’s rapid growth through multiple acquisitions and played a significant part in its eventual buy-out by private equity funds. Before this, he held roles including Group Managing Director and Finance Director of Warner Estate plc, Finance Director of Severn Trent Water, Finance Director of Mowlem Construction, and CFO of BP Marine.
Mark Keogh commented: ”I’m thrilled to be joining Metrion at such an exciting time for the organization. I look forward to working more closely with Keith and the Board, as well as the Company’s excellent executive management team, to support the business as it executes its strategic growth objectives.”
Mark graduated in engineering from University College Dublin, is a member of the Institution of Engineers of Ireland, and holds both ACA and chartered tax adviser qualifications.
For more information: https://www.metrionbiosciences.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
